Impact of PCSK9 inhibitors on lipoprotein(a) levels: a multi-centre study

Harpreet Bhatia(University of California San Diego), Michael J. Wilkinson(University of California San Diego), Ehtisham Mahmud(Cardiovascular Institute of the South), Mattheus Ramsis(University of California San Diego), Raphael Cuomo(University of California San Diego), Pam R. Taub(University of California San Diego Medical Center)
European Journal of Preventive Cardiology
November 17, 2025
10.1093/eurjpc/zwaf734
Cited by 7

Related Papers

2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
|Circulation|2025|524
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
|Journal of the American College of Cardiology|2025|435
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
|Journal of the American College of Cardiology|2020|415
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
|Journal of the American College of Cardiology|2020|395
Correction to: 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
|Circulation|2025|361